Key Insights

Highlights

Success Rate

60% trial completion

Published Results

13 trials with published results (27%)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 75/100

Termination Rate

24.5%

12 terminated out of 49 trials

Success Rate

60.0%

-26.5% vs benchmark

Late-Stage Pipeline

2%

1 trials in Phase 3/4

Results Transparency

72%

13 of 18 completed with results

Key Signals

13 with results60% success12 terminated

Data Visualizations

Phase Distribution

44Total
Not Applicable (11)
Early P 1 (1)
P 1 (11)
P 2 (20)
P 3 (1)

Trial Status

Completed18
Terminated12
Recruiting10
Not Yet Recruiting4
Withdrawn2
Active Not Recruiting2

Trial Success Rate

60.0%

Benchmark: 86.5%

Based on 18 completed trials

Clinical Trials (49)

Showing 20 of 20 trials
NCT07619534Not Yet Recruiting

Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases

NCT02476786Phase 2Recruiting

Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score

NCT07277738Not ApplicableNot Yet Recruiting

Precision Supplemental Imaging in Women With Dense Breasts

NCT04968964Not ApplicableRecruiting

Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing

NCT06981208Not ApplicableRecruiting

ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction

NCT07067138Not ApplicableSuspended

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

NCT07549139Not ApplicableNot Yet Recruiting

Overcoming Racial Disparities in Screening Mammography

NCT05972343Recruiting

COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients

NCT05837455Phase 2Recruiting

NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer

NCT07072728Phase 2Recruiting

Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder

NCT06867484Not ApplicableRecruiting

Breast Re-irradiation After Second Ipsilateral Lumpectomy

NCT00572481Phase 2Active Not RecruitingPrimary

Axillary Reverse Mapping

NCT05252390Phase 1Terminated

NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors

NCT06749210Phase 2RecruitingPrimary

DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY

NCT01766297Phase 2Recruiting

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

NCT01758445Phase 2Active Not Recruiting

Proton Radiation for Stage II/III Breast Cancer

NCT05716542Not ApplicableCompleted

Prehabilitation to Revolutionize Oncology: Telehealth Exercise for Cognitive Triumphs (The PROTECT Trial)

NCT02807597Phase 1Terminated

Real-time Intraoperative Breast Cancer Visualization for Margin Assessment

NCT06711939Not Yet RecruitingPrimary

Vocorder Device Validation in Clinical Settings - Continuous Monitoring of Individuals (Vocorder Clinical Validation-VCV)

NCT06595901Completed

Mental and Cognitive Health and Physical Activity in the Perioperative Breast Cancer Setting

Scroll to load more

Research Network

Activity Timeline